metoprolol has been researched along with Aortic Incompetence in 8 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of metoprolol on cardiac function and myocyte calcium regulatory protein expressions in rabbits with heart failure." | 7.74 | [Effects of metoprolol on cardiac function and myocyte calcium regulatory protein expressions in rabbits with experimental heart failure]. ( Han, LH; Jiang, B; Jiang, TB; Jiang, WP; Li, BY; Li, HX; Liu, ZH; Song, JP; Yang, XJ; Zou, C, 2007) |
| "To investigate the effects of metoprolol on cardiac function and myocyte calcium regulatory protein expressions in rabbits with heart failure." | 3.74 | [Effects of metoprolol on cardiac function and myocyte calcium regulatory protein expressions in rabbits with experimental heart failure]. ( Han, LH; Jiang, B; Jiang, TB; Jiang, WP; Li, BY; Li, HX; Liu, ZH; Song, JP; Yang, XJ; Zou, C, 2007) |
| "Treatment with metoprolol of adults with chronic, moderate to severe AR had no effect on LV volumes." | 2.82 | Controlled release metoprolol for aortic regurgitation: a randomised clinical trial. ( Aakhus, S; Broch, K; Fosså, K; Gullestad, L; Hopp, E; Lønnebakken, MT; Massey, R; Stueflotten, W; Urheim, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broch, K | 2 |
| Urheim, S | 2 |
| Lønnebakken, MT | 1 |
| Stueflotten, W | 2 |
| Massey, R | 2 |
| Fosså, K | 2 |
| Hopp, E | 2 |
| Aakhus, S | 2 |
| Gullestad, L | 2 |
| Evangelista, A | 1 |
| Otto, CM | 1 |
| Champetier, S | 2 |
| Bojmehrani, A | 1 |
| Beaudoin, J | 1 |
| Lachance, D | 3 |
| Plante, E | 3 |
| Roussel, E | 3 |
| Couet, J | 3 |
| Arsenault, M | 3 |
| Gaudreau, M | 1 |
| Drolet, MC | 2 |
| Zou, C | 1 |
| Liu, ZH | 1 |
| Jiang, B | 1 |
| Song, JP | 1 |
| Jiang, TB | 1 |
| Yang, XJ | 1 |
| Li, HX | 1 |
| Han, LH | 1 |
| Li, BY | 1 |
| Jiang, WP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Beta Blockade on Left Ventricular Remodeling and Function in Moderate to Severe Asymptomatic Aortic Regurgitation[NCT01157572] | Phase 4 | 75 participants (Actual) | Interventional | 2010-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for metoprolol and Aortic Incompetence
| Article | Year |
|---|---|
Controlled release metoprolol for aortic regurgitation: a randomised clinical trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aortic Valve Insufficiency; Asymptomatic Diseases; De | 2016 |
7 other studies available for metoprolol and Aortic Incompetence
| Article | Year |
|---|---|
Medical treatment for chronic aortic regurgitation: β-blockers--maybe not bad, but good?
Topics: Adrenergic beta-1 Receptor Antagonists; Aortic Valve Insufficiency; Female; Humans; Male; Metoprolol | 2016 |
Heartbeat: Beta-blockers for aortic regurgitation.
Topics: Adrenergic beta-1 Receptor Antagonists; Aortic Valve Insufficiency; Female; Humans; Male; Metoprolol | 2016 |
Exercise capacity and peak oxygen consumption in asymptomatic patients with chronic aortic regurgitation.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aortic Valve Insufficiency; Asympto | 2016 |
Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorti | 2009 |
Effectiveness of beta-blockade in experimental chronic aortic regurgitation.
Topics: Adrenergic beta-Antagonists; Animals; Aortic Valve Insufficiency; Catecholamines; Cell Size; Chronic | 2004 |
[Effects of metoprolol on cardiac function and myocyte calcium regulatory protein expressions in rabbits with experimental heart failure].
Topics: Animals; Aortic Valve Insufficiency; Calcium; Calcium-Binding Proteins; Disease Models, Animal; Hear | 2007 |
Benefits of long-term beta-blockade in experimental chronic aortic regurgitation.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Anta | 2008 |